MiR-141-3p inhibits human stromal (mesenchymal) stem cell proliferation and differentiation

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 9, 2014, Pages 2114-2121

  Qiu, Weimin ^a   Kassem, Moustapha ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

CDC25A; Cell proliferation and differentiation; Human stromal (mesenchymal) stem cell; MiRNA; Wnt signaling

Indexed keywords

ALKALINE PHOSPHATASE; CELL DIVISION CYCLE 25 A PROTEIN; MICRORNA; MICRORNA 141 3P; NOCODAZOLE; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADIPOCYTE; ANIMAL CELL; ARTICLE; BONE MASS; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN TARGETING; WESTERN BLOTTING;

CDC25A; CELL PROLIFERATION AND DIFFERENTIATION; HUMAN STROMAL (MESENCHYMAL) STEM CELL; MIRNA; WNT SIGNALING;

ANIMALS; BASE SEQUENCE; CDC25 PHOSPHATASES; CELL DIFFERENTIATION; CELL PROLIFERATION; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICRORNAS; MOLECULAR SEQUENCE DATA; OSTEOBLASTS; WNT SIGNALING PATHWAY;

EID: 84903192700     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.06.004     Document Type: Article

References (38)

1. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 2004, 5:522-531.
2. Taipaleenmaki H., Bjerre Hokland L., Chen L., Kauppinen S., Kassem M. Mechanisms in endocrinology: micro-RNAs: targets for enhancing osteoblast differentiation and bone formation. Eur. J. Endocrinol. 2012, 166:359-371.
3. Lim L.P., Lau N.C., Garrett-Engele P., Grimson A., Schelter J.M., Castle J., Bartel D.P., Linsley P.S., Johnson J.M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773.
4. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011, 39:D152-D157.
5. Olsen P.H., Ambros V. The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev. Biol. 1999, 216:671-680.
6. Hutvagner G., Zamore P.D. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002, 297:2056-2060.
7. Llave C., Xie Z., Kasschau K.D., Carrington J.C. Cleavage of Scarecrow-like mRNA targets directed by a class of Arabidopsis miRNA. Science 2002, 297:2053-2056.
8. Janowski B.A., Younger S.T., Hardy D.B., Ram R., Huffman K.E., Corey D.R. Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat. Chem. Biol. 2007, 3:166-173.
9. Khraiwesh B., Arif M.A., Seumel G.I., Ossowski S., Weigel D., Reski R., Frank W. Transcriptional control of gene expression by microRNAs. Cell 2010, 140:111-122.
10. Lian J.B., Stein G.S., van Wijnen A.J., Stein J.L., Hassan M.Q., Gaur T., Zhang Y. MicroRNA control of bone formation and homeostasis. Nat. Rev. Endocrinol. 2012, 8:212-227.
11. Eskildsen T., Taipaleenmaki H., Stenvang J., Abdallah B.M., Ditzel N., Nossent A.Y., Bak M., Kauppinen S., Kassem M. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:6139-6144.
12. Eguchi T., Watanabe K., Hara E.S., Ono M., Kuboki T., Calderwood S.K. OstemiR: a novel panel of microRNA biomarkers in osteoblastic and osteocytic differentiation from mesencymal stem cells. PLoS One 2013, 8:e58796.
13. Abdallah B.M., Kassem M. Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther. 2008, 15:109-116.
14. Gimble J.M., Zvonic S., Floyd Z.E., Kassem M., Nuttall M.E. Playing with bone and fat. J. Cell. Biochem. 2006, 98:251-266.
15. Qiu W., Andersen T.E., Bollerslev J., Mandrup S., Abdallah B.M., Kassem M. Patients with high bone mass phenotype exhibit enhanced osteoblast differentiation and inhibition of adipogenesis of human mesenchymal stem cells. J. Bone Miner. Res. 2007, 22:1720-1731.
16. Kapinas K., Kessler C.B., Delany A.M. miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. J. Cell. Biochem. 2009, 108:216-224.
17. Li Z., Hassan M.Q., Jafferji M., Aqeilan R.I., Garzon R., Croce C.M., van Wijnen A.J., Stein J.L., Stein G.S., Lian J.B. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J. Biol. Chem. 2009, 284:15676-15684.
18. Kapinas K., Kessler C., Ricks T., Gronowicz G., Delany A.M. miR-29 modulates Wnt signaling in human osteoblasts through a positive feedback loop. J. Biol. Chem. 2010, 285:25221-25231.
19. Wang T., Xu Z. miR-27 promotes osteoblast differentiation by modulating Wnt signaling. Biochem. Biophys. Res. Commun. 2010, 402:186-189.
20. Zhang J., Tu Q., Bonewald L.F., He X., Stein G., Lian J., Chen J. Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J. Bone Miner. Res. 2011, 26:1953-1963.
21. Simonsen J.L., Rosada C., Serakinci N., Justesen J., Stenderup K., Rattan S.I., Jensen T.G., Kassem M. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat. Biotechnol. 2002, 20:592-596.
22. Al-Nbaheen M., Vishnubalaji R., Ali D., Bouslimi A., Al-Jassir F., Megges M., Prigione A., Adjaye J., Kassem M., Aldahmash A. Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential. Stem Cell Rev. 2013, 9:32-43.
23. Qiu W., Hu Y., Andersen T.E., Jafari A., Li N., Chen W., Kassem M. Tumor necrosis factor receptor superfamily member 19 (TNFRSF19) regulates differentiation fate of human mesenchymal (stromal) stem cells through canonical Wnt signaling and C/EBP. J. Biol. Chem. 2010, 285:14438-14449.
24. Qiu W., Chen L., Kassem M. Activation of non-canonical Wnt/JNK pathway by Wnt3a is associated with differentiation fate determination of human bone marrow stromal (mesenchymal) stem cells. Biochem. Biophys. Res. Commun. 2011, 413:98-104.
25. Betel D., Wilson M., Gabow A., Marks D.S., Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008, 36:D149-D153.
26. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., Rajewsky N. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
27. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
28. Vergoulis T., Vlachos I.S., Alexiou P., Georgakilas G., Maragkakis M., Reczko M., Gerangelos S., Koziris N., Dalamagas T., Hatzigeorgiou A.G. TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res. 2012, 40:D222-D229.
29. Boutros R., Lobjois V., Ducommun B. CDC25 phosphatases in cancer cells: key players? Good targets?. Nat. Rev. Cancer 2007, 7:495-507.
30. Zhang L., Deng T., Li X., Liu H., Zhou H., Ma J., Wu M., Zhou M., Shen S., Niu Z., Zhang W., Shi L., Xiang B., Lu J., Wang L., Li D., Tang H., Li G. microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. Carcinogenesis 2010, 31:559-566.
31. Korpal M., Kang Y. The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol. 2008, 5:115-119.
32. Renthal N.E., Williams K.C., Mendelson C.R. MicroRNAs-mediators of myometrial contractility during pregnancy and labour. Nat. Rev. Endocrinol. 2013, 9:391-401.
33. Dykxhoorn D.M., Wu Y., Xie H., Yu F., Lal A., Petrocca F., Martinvalet D., Song E., Lim B., Lieberman J. miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One 2009, 4:e7181.
34. Du Y., Xu Y., Ding L., Yao H., Yu H., Zhou T., Si J. Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. J. Gastroenterol. 2009, 44:556-561.
35. Yu X.Y., Zhang Z., Liu J., Zhan B., Kong C.Z. MicroRNA-141 is downregulated in human renal cell carcinoma and regulates cell survival by targeting CDC25B. Oncol. Targets Ther. 2013, 6:349-354.
36. Itoh T., Nozawa Y., Akao Y. MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J. Biol. Chem. 2009, 284:19272-19279.
37. Lee G., White L.S., Hurov K.E., Stappenbeck T.S., Piwnica-Worms H. Response of small intestinal epithelial cells to acute disruption of cell division through CDC25 deletion. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:4701-4706.
38. Lee G., Origanti S., White L.S., Sun J., Stappenbeck T.S., Piwnica-Worms H. Contributions made by CDC25 phosphatases to proliferation of intestinal epithelial stem and progenitor cells. PLoS One 2011, 6:e15561.